tiprankstipranks
Trending News
More News >
PharmaSGP Holding SE (DE:PSG)
HAMBURG:PSG
Germany Market

PharmaSGP Holding SE (PSG) Income Statement

Compare
7 Followers

PharmaSGP Holding SE Income Statement

Last quarter (Q1 2025), PharmaSGP Holding SE's total revenue was €33.47M, an increase of 10.81% from the same quarter last year. In Q1, PharmaSGP Holding SE's net income was €4.73M. See PharmaSGP Holding SE’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 118.84M€ 101.10M€ 85.82M€ 65.34M€ 63.25M
Gross Profit
€ 107.99M€ 91.64M€ 76.79M€ 58.86M€ 57.04M
Operating Expenses
€ 80.35M€ 67.00M€ 59.11M€ 43.36M€ 40.97M
Depreciation and Amortization
€ 9.41M€ 9.30M€ 9.19M€ 3.57M€ 486.00K
EBITDA
€ 39.59M€ 35.87M€ 27.18M€ 18.49M€ 14.74M
Operating Income
€ 27.64M€ 24.64M€ 17.60M€ 15.42M€ 16.05M
Other Income/Expenses
€ -1.60M€ -2.75M€ -3.24M€ -1.46M€ -735.00K
Pretax Income
€ 26.04M€ 21.89M€ 15.80M€ 14.21M€ 14.15M
Net Income
€ 19.54M€ 16.40M€ 11.95M€ 10.69M€ 10.64M
Per Share Metrics
Basic EPS
€ 1.65€ 1.37€ 1.00€ 0.89€ 0.89
Diluted EPS
€ 1.65€ 1.37€ 1.00€ 0.89€ 0.89
Weighted Average Shares Outstanding
11.87M 11.99M 12.00M 12.00M 12.00M
Weighted Average Shares Outstanding (Diluted)
11.87M 11.99M 12.00M 12.00M 12.00M
Currency in EUR

PharmaSGP Holding SE Earnings and Revenue History